Antiretroviral therapy (ART) started to become more widely available in Vietnam in 2005. However, up to now, very little is known about factors influencing ART adherence among people living with HIV (PLHIV) in Vietnam. This qualitative study aimed to describe factors influencing ART adherence among PLHIV in a northern province in Vietnam, and to explore possibilities of home delivery of ART. Forty-eight participants (36 men and 12 women), including patients on ART and their relatives, were divided in seven focus group discussions. The topics discussed included: adherence obstacles encountered during ART, methods patients used to enhance adherence, treatment support structures, and attitudes toward home delivery of ART. All interviews were audio-recorded, then transcribed in Vietnamese. Manual manifest and latent content analysis was applied for data analysis in order to elucidate the presence of, meaning of, and relationships between concepts in the text. Stigma was identified as a strong barrier to ART adherence, as patients feared that taking medications in the presence of other persons would lead to suspicion or inadvertent disclosure of their HIV status. In addition to desires for non-disclosure influencing PLHIV's adherence, it also shaped their attitudes toward opting for more confidential ways of receiving ART support and care. Home delivery of ART medications was seen as undesirable by participants, who feared that it might increase social stigmatization. Participants wished for more community-based support, preferably from PLHIV who had received sufficient training. Based on the results of this study, an intervention strategy using PLHIV as community-based adherence supporters is currently being evaluated in a randomized controlled trial intervention, including 640 patients in Quang Ninh, Vietnam.
Introduction
Globally, HIV is the leading infectious cause of adult death with more than 90% of deaths occurring in lowincome countries (UNAIDS, 2008a) . Providing antiretroviral therapy (ART) to people living with HIV (PLHIV) has both individual and public health benefits, including reduced infectivity, longer life expectancy, and improved health status (Anema, Wood & Montaner, 2008; UNAIDS, 2008b) . However, unless the drugs are properly taken, first-line ART could rapidly become of limited value due to virological failure and drug resistance. Poor adherence has greater implications in low-income settings as viral load monitoring is often not available and options for second-line treatment are limited (Ahoua et al., 2009; Bangsberg et al., 2006; Bangsberg, Moss, & Deeks 2004; Weidle et al., 2006) .
In Vietnam, although the HIV epidemic is in a concentrated stage with most cases among injection drug users (IDUs) and sex workers (UNAIDS, 2008b) , the number of PLHIV is increasing in the general population fueled by social vulnerability and gender inequalities (Nguyen, Oosterhoff, et al., 2008; Phinney, 2008) . In 2008, the HIV prevalence among adults aged 15Á49 was estimated to be 0.43% (Vietnam Administration for AIDS Control, 2009). By mid-2009 about 32,000 PLHIV had access to ART free-of-charge; however, scale-up of ART faces challenges, including shortages of health care personnel willing to work with HIV-infected individuals resulting in heavy work loads and constrained adherence support (Vietnam Administration for AIDS Control, 2009 ).
Data are limited as to how to improve ART adherence in resource-limited settings. Directly observed therapy (DOT), originally developed for tuberculosis treatment, has been used with ART and has shown some effect in other settings (Farmer et al., 2001; Smith-Rohrberg, Mezger, Walton, Bruce, & Altice, 2006; Weidle et al., 2006) . However, DOT is resource-intensive and often not well-accepted by patients (Huong et al., 2006; Ngamvithayapong, *Corresponding author. Email: tamvanvu@yahoo.com Care Vol. 23, No. 2, February 2011 , 139Á145 Yanai, Winkvist, Saisorn, & Diwan, 2001 . The aim of the present study was to describe factors influencing ART adherence among PLHIV in Vietnam, including whether a modified-DOT approach of home-based ART delivery would be acceptable to HIV patients. Study results were used to inform the design of a contextspecific intervention to improve ART adherence.
AIDS

Methods
Study setting
The study was conducted at the HIV/AIDS outpatient clinic (OPC) in Uong Bi hospital, Quang Ninh province. This northeastern costal province has 1.2 million inhabitants and a rapidly growing economy based on coal, cement, and tourist industries. Quang Ninh is estimated to have the highest HIV prevalence in Vietnam, with about 1% of the adult population living with HIV (Ministry of Health of Vietnam, 2005) .
Participants and data collection
Study participants were selected from the group of 70 patients receiving ART at the OPC of Uong Bi Hospital and residing in Quang Ninh, as well as some patients' family members (parents or spouses) who had been providing support to the patients during the course of their treatment. Participants were purposively selected based on the duration of time that they had been on ART and residence in the study province. Family members were recruited through patient participants. Participants were contacted at the OPC or by telephone and given information about the purpose of the focus group discussions (FGD); those giving verbal consent to participate were included. In total, there were 48 participants divided into seven FGDs: four groups with male patients (n024), one group with female patients (n07), one mixed group with male and female patients (n08), and one group with male and female family members (n09). Patient groups were organized based on duration on ART (from two weeks up to seven months).
A discussion guide was developed in English, translated into Vietnamese, and initially piloted in one FGD. Topics discussed included: major adherence obstacles encountered during ART, strategies for PLHIV to enhance ART adherence, support received from family members when taking ART, suggestions for how to further improve adherence, and the feasibility of ART home delivery. Probes were used when necessary to explore the topics more in-depth.
FGDs were conducted in a private meeting room at the OPC in Uong Bi hospital and lasted 90Á120 minutes. Discussions were conducted in Vietnamese and were moderated by the first author (Vu Van Tam) (four groups) or another trained FGD moderator, both native speakers of Vietnamese. All groups were observed and notes were taken regarding non-verbal communication and group interaction. The content of each FGD was recorded and transcribed verbatim. Spot checks of the transcriptions were carried out to ensure the quality of the transcript. The identity of the speaker was dissociated from the transcript once the transcripts were finalized.
Ethical permission was obtained from Hanoi Medical University.
Analysis
Manifest and latent content analysis were applied for data analysis. Content analysis is a qualitative method which focuses on the presence of, meaning of, and relationships between concepts in text, emphasizing variation within and between what is described outright (manifest content) and underlying meanings (latent content) in the text (Elo & Kyngas, 2008; Graneheim & Lundman, 2004) . All the transcripts were read through a number of times until there was a sense of familiarity with the data. Coding and categorizing were performed manually and inductively, in stages. The first stage consisted of identifying meaning units, where phrases in the transcript were underlined and then restated in the margins as codes. From the codes, categories were developed and then further compared and merged into a theme. The research group includes five people, two females, and three males with medical, nursing, and public health backgrounds.
Findings
Of the 48 participants interviewed (36 men and 12 women), 60% were married and 87% under 35 years (Table 1) . Among the PLHIV interviewed, about half had another PLHIV in their family.
The overarching theme of the discussions was that PLHIV's views on ART adherence and optimal care delivery are influenced by their experiences of HIVrelated stigma. Results relating to this theme will be presented in five categories: stigma-related barriers to ART adherence, strategies for ART adherence, PLHIV's needs for support in adhering to ART, PLHIV do not want home-based DOT, and PLHIV can provide support to other PLHIV.
Stigma-related barriers to antiretroviral therapy (ART) adherence
Experiences and fears of HIV-associated stigma from the community were widely acknowledged in both male and female groups. Most participants brought up fears that taking their medication would reveal their HIV status to family members, friends, neighbors, or co-workers and this was stated as a main barrier to ART adherence: I'm very reluctant to take out the drugs. It is not that I forget, it's just that I don't want other people to know. At times, I feel alienated. When you go out into the community or even with your relatives you feel ill at ease. (Female, 28 years, five months on ART) Concern with HIV-associated stigma was especially emphasized by those living and working in crowded conditions such markets, boats, offices, or coal mines, making it difficult to ensure privacy at dose-taking times:
None of us could take ARV medications in public. Other people would avoid you if they became aware that you got the disease while you try to conceal it. It would be terrible if suddenly people recognize who I am. (Male, 32 years, six months on ART) Participants in both the female and male groups described fears of stigma or discrimination toward their family members if others found out about their HIV status. Male participants also described fears that others would suspect them of using illicit drugs if observed taking their ART dose.
Strategies for antiretroviral therapy (ART) adherence
Despite the commonly reported barriers to ART adherence, nearly all of the participants expressed a belief in the importance of ART and described strategies which they enacted to adhere to their medication regimen. A few participants reported no difficulties with ART adherence, however, most participants described taking their medications in a hidden manner in order to prevent unwanted disclosure of their HIV status to others. When at work, a majority of participants described trying to avoid suspicion by concealing or disguising their ART medication. Others lied about the type of medication that they were taking or delayed taking the medication until they could do so privately.
Particularly during the first stage of ART, participants in both patient and relative groups reported that patients had to rely on reminders from relatives in order to actually take the dose:
Most important is that some people living close can remind us to take drugs. My parents provide me with great support. If at that time (when ART should be taken) the alarm clock is still silent, they will wake me up and remind me to take the drugs. (Male, 28 years, one month on ART) However, those family members who played a supportive role in the beginning of treatment often, after some time, were described as assuming that the PLHIV was taking the drugs as prescribed and asking less frequently about whether the ART was being taken.
In the cases where participants described experiencing symptoms and feeling unsure if they should take ART, more than half of participants reported AIDS Care 141 that they often called health staff for advice and, if reached, they were more likely to take the ART dose. However, many felt unease about bothering or disrupting health staff.
People living with HIV's (PLHIV) needs for support in adhering to antiretroviral therapy (ART)
Participants in the patient groups acknowledged that the counseling given before starting ART was helpful, however, some participants, particularly in the group of patients who had recently started ART, expressed great worry about the side effects of ART and desired more communication with health staff in order to allay their fears. In all groups, both women and men described desiring more information about ART and its side effects as well as moral support. Women more often focused on moral support, such as this female participant who describes her desire for support in communicating with her husband's family: The majority held the opinion that distributing medication daily at home was not feasible and would be impossible for persons who traveled for work. Most patients preferred to go to the health center to check their health status and to collect their medications. However, some participants acknowledged the inconvenience of being present at the clinic regularly and that doctors and other health staff were too busy to spend adequate time with them.
People living with HIV (PLHIV) can provide support to other PLHIV
When discussing what type of person could best give moral and adherence support to PLHIV, all participants agreed that while health workers could provide additional support, the community-based adherence supporter should be ''in the same situation'' and experienced in taking ART, in order to more easily show sympathy and help patients to talk to relatives or health care providers if needed. As this male patient explains:
A patient would know how to take the medicine . . . as he himself has been through this. They can sympathize with you. After all we suffer from the same disease. We have lots of things in common and can easily strike up a conversation. A person without HIV would be difficult to share your problems with because he wouldn't understand you. (Male, 37 years, seven months on ART)
PLHIV were also thought to be able to share strategies for taking medications with each other, as this family member points out: Participants suggested that support could be given by PLHIV who were selected by peers and given appropriate training. It was underscored by about half of the participants, though, that they would not appreciate peer-support from PLHIV who were active drug users, as they were perceived to be untrustworthy. About half of the female participants stated that they could more easily share their problems and concerns with other women living with HIV.
Discussion
This study aimed to describe factors influencing adherence to prescribed ART among PLHIV in Vietnam. Stigma was identified as a strong barrier to ART adherence, as PLHIV feared that other persons' knowledge of their medications would lead to suspicions or inadvertent disclosure of their HIV status. This influenced PLHIV's attitudes toward the acceptability of home delivery of medication and led them to prefer receiving community support from other PLHIV. Most of the barriers to adherence described by participants in this study were driven by fears of HIVrelated stigma against themselves and their relatives. Despite the stigma-related as well as logistical barriers to adherence described in this setting, which are also reported elsewhere (Murray et al., 2009; Talam, Gatongi, Rotich, & Kimaiyo, 2008) , the majority of participants also described how they enacted strategies to overcome these barriers (Kumarasamy et al., 2005; Ware et al., 2009; Watt et al., 2009) . Family member reminders were described as a strategy for adherence support in the beginning of treatment. However, reminders decreased over time and this could lead to a reduction in ART adherence due to a lack of constant reminding and support. This points to a need for additional support outside of the immediate family (Gill, Hamer, Simon, Thea, & Sabin 2005) .
Participants in our study described strong desires for adherence support (Englert et al., 2001; Rischitelli, 1995) . While we had planned on using health workers to provide support for the intervention, well-trained PLHIV community-based supporters were seen as the best source of support as they would be able to act as intermediaries between patients and health care providers, giving information, counseling, and assisting patients to contact health staff when needed, thereby improving adherence (Malta, Petersen, Freitas, & Bastos, 2005; Marelich & Murphy, 2003) .
Contrary to what we had thought prior to conducting this study, participants did not want to receive ART medications at home, as they feared it might increase the risk of HIV-related stigma for them and their families. In settings with heavy HIV-related stigma and discrimination, such as Vietnam (Gaudine, Gien, Thuan, & Dung Do, 2009; Khuat, Thi Van Anh, & Ogden, 2004) , desires to guard against the disclosure of one's HIV status could lead to non-participation in HIV programs and reduce adherence. The balance of ensuring confidentiality while scaling-up HIV care must be addressed to support both adherence and access to ART.
Participants in this study appeared to welcome involvement in their own treatment and listed several ways in which PLHIV could provide peersupport for adherence to ART. Considering the limited human resources for health care and increasing numbers of PLHIV (Barnighausen, Bloom, & Humair, 2007) , peer-support among PLHIV should be assessed as a strategy to reduce the burden of work, cost of care, improve adherence to ART, strengthen the role of PLHIV, and most importantly, reduce stigma in the community, through the empowerment of PLHIV (Altice, Maru, Bruce, Springer, & Friedland, 2007) .
The results of the study have been used to inform a randomized controlled trial (RCT) in the study area to assess the effect of community-based peer-support on adherence and virological treatment failure rates. Trained PLHIV peer-supporters are the cornerstone of the adherence intervention. In fact, some of the participants in this study were later recruited as peersupporters. Intensive adherence support with twice weekly visits is provided during the initial two months of ART when questions about side effects were reported to be common and when drug-taking habits are formed. Then, later on, supportive visits are reduced to once a week if adherence is good, and intensified if adherence is poor. As home delivery of medications was not desired, patients pick up their medications at the clinic in monthly doses. In the design of the intervention, we have tried to uphold patients' desires for privacy related to their HIV status while maximizing their participation in their own care with the hope that they will have a greater likelihood of remaining in the ART program and achieving higher adherence.
Methodological concerns
This is a qualitative study, which, by design, includes a small number of participants and seeks to explore ideas in-depth. Qualitative findings are limited in their generalizability, however, we believe that these results can provide useful information within Vietnam and similar settings. In our study, participants had all previously received counseling and training about adherence, therefore, responses may have been influenced by social desirability. It may have also been difficult to discuss active illicit drug use in the FGD setting. We did not have data on actual practices of adherence, but the discussions included active member participation, where HIV-related stigma and cases of non-adherence were brought up freely.
Conclusion
Stigma was described as the main barrier to ART adherence in this setting. Home-based DOT of ART medication was not seen as acceptable as it was perceived as having the potential to increase social stigmatization. Participants wished for more support in adhering to ART and the best form of support was described to be community-based peer-support by other PLHIV who had received sufficient training. Based on the results of this study, an intervention strategy using PLHIV as community-based adherence AIDS Care 143 supporters is currently being evaluated in a RCT intervention, including 640 patients in Quang Ninh, Vietnam.
